Mathias Schmidt
Company: ArmaGen
Job title: CEO
Seminars:
Valanafusp-Alpha: The Development Path of a Brain Penetrating Molecular Enzyme Replacement Therapy for the Treatment of Neurological & Somatic Symptoms pf MPS I 11:30 am
day: Day One
Live Q&A Session 12:20 pm
day: Day One
Valanafusp-Alpha: The Development Path of a Brain Penetrating Molecular Enzyme Replacement Therapy for the Treatment of Neurological & Somatic Symptoms pf MPS I 11:30 am
day: Day One
Live Q&A Session 12:20 pm
day: Day One
Valanafusp-Alpha: The Development Path of a Brain Penetrating Molecular Enzyme Replacement Therapy for the Treatment of Neurological & Somatic Symptoms pf MPS I 11:30 am
day: Day One